Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 25, 2017. The document serves as a transaction notification regarding the vesting of deferred investment awards for specific Persons Discharging Managerial Responsibilities (PDMRs) under the GlaxoSmithKline Deferred Investment Award Plan.
Key Financial Metrics
The filing does not report consolidated revenue, profit, cash flow, margins, debt, or liquidity metrics. It exclusively details specific executive compensation transactions.
| Executive | Position | Transaction Date | Notional Shares | Price per Share | Cash Payment (Gross) |
|---|---|---|---|---|---|
| Ms E Walmsley | Chief Executive Officer | 2017-09-23 | 18,970.518 | £14.7175 | £279,198.61 |
| Mr R G Connor | President, Global Manufacturing & Supply | 2017-09-23 | 7,588.207 | £14.7175 | £111,679.44 |
| Mr D S Redfern | Chief Strategy Officer | 2017-09-23 | 7,588.207 | £14.7175 | £111,679.44 |
| Ms C Thomas | SVP, Human Resources | 2017-09-23 | 7,588.207 | £14.7175 | £111,679.44 |
| Dr P J T Vallance | President, Pharmaceuticals | 2017-09-23 | 9,485.259 | £14.7175 | £139,599.30 |
Material Changes
The filing does not provide comparative financial data or material changes to the company's overall business operations versus prior periods. The only reported activity is the scheduled vesting of awards originally granted on June 12, 2014.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a statutory disclosure of specific equity-based compensation events.
Investor Verification Checklist
- Verify the total cash outflow for these specific executive awards is approximately £753,836.23 (sum of gross payments).
- Confirm that all transactions were settled in cash rather than physical share delivery, as indicated by the "cash payment" language.
- Note that the share price used for valuation was £14.7175 on the vesting date of September 23, 2017.
- Recognize that this filing does not reflect the company's broader financial performance for the quarter or year.